Pension & Wealth Management Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-270
Closed -$7.82K – 516
2025
Q4
$7.82K Buy
270
+222
+463% +$6.66K ﹤0.01% 426
2025
Q3
$1.33K Hold
48
– – ﹤0.01% 498
2025
Q2
$1.17K Hold
48
– – ﹤0.01% 454
2025
Q1
$996 Hold
48
– – ﹤0.01% 440
2024
Q4
$1.13K Hold
48
– – ﹤0.01% 434
2024
Q3
$1.23K Hold
48
– – ﹤0.01% 337
2024
Q2
$1.13K Sell
48
-428
-90% -$10.8K ﹤0.01% 327
2024
Q1
$13.7K Hold
476
– – 0.01% 264
2023
Q4
$15.6K Buy
476
+208
+78% +$5.66K 0.01% 234
2023
Q3
$7.47K Hold
268
– – 0.01% 213
2023
Q2
$9.14K Hold
268
– – 0.01% 207
2023
Q1
$8.06K Hold
268
– – 0.01% 224
2022
Q4
$7.57K Buy
+268
New +$8.51K 0.01% 217

Other funds holding ARKG

Pension & Wealth Management Advisors's ARKG Position: Q1 2026 in Review

Pension & Wealth Management Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 270 shares — an estimated $7.82K sold.

Pension & Wealth Management Advisors first reported a position in ARKG in Q4 2022 and held it in 13 quarters. The position peaked at $15.6K in Q4 2023. 220 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Pension & Wealth Management Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Pension & Wealth Management Advisors sold 270 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $7.82K.
  • Pension & Wealth Management Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 13 quarters.
  • Pension & Wealth Management Advisors's ARK Genomic Revolution ETF position peaked at $15.6K in Q4 2023.
  • 220 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Pension & Wealth Management Advisors's 13F filing for Q1 2026, filed 7 Aug 2026.